news aktuell GmbH

Biomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services

Biomay's aseptic filling line. Credits: Biomay AG
Biomay's aseptic filling line. Credits: Biomay AG

Vienna, November 13, 2023

Biomay expanded its biomanufacturing facility in central Vienna, 9th district, by adding clean rooms, laboratories, and warehouse premises in the Vienna Competence Center building. Besides the 4000 sqm main site in Vienna 22nd district, Biomay now operates an additional 2000 sqm integrated biomanufacturing facility, equipped with five GMP-commissioned clean rooms for upstream and downstream processing and aseptic filling. Furthermore, the site features comprehensive laboratories for quality control, process and assay development.

A New Center of Excellence for mRNA

The upgraded site will serve as Biomay's Center of Excellence for end-to-end Contract Development and Manufacturing Organization (CDMO) services, specifically for messenger RNA (mRNA) manufacturing. The GMP service offerings for mRNA include plasmid cell banking, circular plasmid and linear DNA template manufacturing, in-vitro transcription (IVT) of mRNA drug substance, and aseptic filling of mRNA drug product. Biomay employs cutting-edge enzymatic run-off transcription based on linear DNA templates for mRNA processing, offering various options for 5´-capping, 3´-poly-adenylation, and nucleotide modification as per client requirements.

Notably, Biomay has a strong track record in GMP production of linear DNA templates, supplying significant amounts of these templates during the COVID-19 pandemic for the manufacturing of a COVID-19 mRNA vaccine. The company has also gained extensive experience in GMP manufacturing of DNA templates for other clinical indications, such as oncology.

Aseptic Filling Capacities

Biomay's aseptic filling capacities include a seven-glove isolator equipped with an automated processing line for aseptic filling, vial capping and crimping, primarily serving clinical-stage investigational medicinal products (IMPs). Dr. Angela Neubauer, the Site Head of the facility and Biomay's Senior Vice President Client Business, emphasized the company's evolution from being a drug substance and API manufacturer to offering drug product aseptic filling, testing and release services. She highlighted Biomay's strategic goal of establishing itself as a leading player in the mRNA CDMO field, alongside its existing expertise in proteins and plasmids.


Dr. Angela NeubauerSVP Client BusinessBiomay AG

Ada Lovelace-Str. 2
A-1220 Vienna, Austria


Biomay's aseptic filling line. Credits: Biomay AG
Biomay's aseptic filling line. Credits: Biomay AG


About Biomay

Founded in 1984, Biomay AG is a fully integrated CDMO with a focus on microbial based  GMP services for manufacturing therapeutic proteins, plasmid DNA and mRNA. The new site complements Biomay’s main manufacturing site in Vienna Seestadt (22nd district, Ada Lovelace-Strasse), established in 2021.

About news aktuell GmbH

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study15.2.2024 09:00:00 CET | Press release

Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy of ACOU085 in patients with testicular cancer undergoing high-dose cisplatin-based chemotherapy regimens (cis-Pt ≥300 mg/m2).

PAPACKS: 100-Million Coffee Capsule Deal: PAPACKS and EURO-CAPS Conquer the Market with Plastic-Free Innovation and Win the Prestigious WorldStar Packaging Award13.2.2024 09:45:00 CET | Press release

The coffee capsule, developed together in a more than five-year fantastic collaboration between Euro-Caps and PAPACKS, is made from renewable, FSC®-certified raw materials, representing a significant advancement in the sustainable packaging industry. It greatly minimizes waste and optimizes resource usage.

The 2025 HÄUSER-AWARD: simply good houses. The search is on for individual detached houses that are suitable for everyday life12.2.2024 10:15:27 CET | Press release

Building has become increasingly complex and complicated in recent years, especially in terms of construction and building technology. But even in architecture, the most convincing solutions do not necessarily have to be the most elaborate - on the contrary. Focusing on the essentials, rethinking and redefining requirements is more important than ever in times of climate change, energy crisis and scarce resources - and makes both economic and ecological sense.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye